» Articles » PMID: 17307945

Gamma Interferon Responses of CD4 and CD8 T-cell Subsets Are Quantitatively Different and Independent of Each Other During Pulmonary Mycobacterium Bovis BCG Infection

Overview
Journal Infect Immun
Date 2007 Feb 20
PMID 17307945
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Gamma interferon (IFN-gamma) is a key cytokine in host defense against intracellular mycobacterial infection. It has been believed that both CD4 and CD8 T cells are the primary sources of IFN-gamma. However, the relative contributions of CD4 and CD8 T-cell subsets to IFN-gamma production and the relationship between CD4 and CD8 T-cell activation have not been examined. By using a model of pulmonary mycobacterial infection and various immunodetection assays, we found that CD4 T cells mounted a much stronger IFN-gamma response than CD8 T cells at various times after mycobacterial infection, and this pronounced IFN-gamma production by CD4 T cells was attributed to both greater numbers of antigen-specific CD4 T cells and a greater IFN-gamma secretion capacity of these cells. By using major histocompatibility complex class II-deficient or CD4-deficient mice, we found that the lack of CD4 T cells did not negatively affect primary or secondary CD8 T-cell IFN-gamma responses. The CD8 T cells activated in the absence of CD4 T cells were capable of immune protection against secondary mycobacterial challenge. Our results suggest that, whereas both CD4 and CD8 T cells are capable of IFN-gamma production, the former represent a much greater cellular source of IFN-gamma. Moreover, during mycobacterial infection, CD8 T-cell IFN-gamma responses and activation are independent of CD4 T-cell activation.

Citing Articles

B2M or CIITA knockdown decreased the alloimmune response of dental pulp stem cells: an in vitro study.

Hu M, Zhang Y, Liu J, Chen Y, Kang J, Zhong J Stem Cell Res Ther. 2024; 15(1):425.

PMID: 39538338 PMC: 11562604. DOI: 10.1186/s13287-024-04023-5.


-Human Immunodeficiency Virus Infection and the Role of T Cells in Protection.

Hosseinian K, Gerami A, Bral M, Venketaraman V Vaccines (Basel). 2024; 12(7).

PMID: 39066368 PMC: 11281535. DOI: 10.3390/vaccines12070730.


Agent-based model predicts that layered structure and 3D movement work synergistically to reduce bacterial load in 3D in vitro models of tuberculosis granuloma.

Petrucciani A, Hoerter A, Kotze L, Plessis N, Pienaar E PLoS Comput Biol. 2024; 20(7):e1012266.

PMID: 38995971 PMC: 11288457. DOI: 10.1371/journal.pcbi.1012266.


The efficacy of cercarial antigen loaded on nanoparticles as a potential vaccine candidate in -infected mice.

Elguindy D, Ashour D, Elmarhoumy S, El-Guindy D, Ismail H J Parasit Dis. 2024; 48(2):381-399.

PMID: 38840868 PMC: 11147980. DOI: 10.1007/s12639-024-01677-z.


The changes and its significance of peripheral blood NK cells in patients with tuberculous meningitis.

Mi J, Liu Y, Xue Y, Sun W, Liang Y, Liang J Front Microbiol. 2024; 15:1344162.

PMID: 38486698 PMC: 10937341. DOI: 10.3389/fmicb.2024.1344162.


References
1.
Xing Z, Zganiacz A, Wang J, Sharma S . Enhanced protection against fatal mycobacterial infection in SCID beige mice by reshaping innate immunity with IFN-gamma transgene. J Immunol. 2001; 167(1):375-83. DOI: 10.4049/jimmunol.167.1.375. View

2.
Frucht D, Fukao T, Bogdan C, Schindler H, Oshea J, Koyasu S . IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 2001; 22(10):556-60. DOI: 10.1016/s1471-4906(01)02005-1. View

3.
Serbina N, Lazarevic V, Flynn J . CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J Immunol. 2001; 167(12):6991-7000. DOI: 10.4049/jimmunol.167.12.6991. View

4.
Turner J, Frank A, Orme I . Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells. Infect Immun. 2002; 70(8):4628-37. PMC: 128196. DOI: 10.1128/IAI.70.8.4628-4637.2002. View

5.
Saunders B, Frank A, Orme I, Cooper A . CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol. 2002; 216(1-2):65-72. DOI: 10.1016/s0008-8749(02)00510-5. View